Heterobicylic inhibitors of hcv

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/519 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2602294

Fused bicyclic pyrimidine compounds having an amide-substituted pyridylamine group at C-4 of the pyrimidine of formula (I) ring are useftul in the treatment of conditions associated with HCV.

L'invention concerne des composés de pyrimidine bicycliques fusionnés comprenant un groupe pyridylamine à substitution amide en position C-4 du noyau de pyrimidine représenté par la formule (I). Ces composés sont utiles dans le traitement de maladies associées au VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterobicylic inhibitors of hcv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterobicylic inhibitors of hcv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicylic inhibitors of hcv will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2011697

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.